In myeloid leukemia (Zhang et al., 2023), hepatocellular carcinoma, Hodgkin’s lymphoma, head and neck carcinoma (Liao et al., 2023), and pancreatic cancer, FTH1 has been shown to act as an oncogene. This evidence concerns the gene FTH1 and familial pancreatic carcinoma.